The Lancet Respiratory Medicine in conversation with (The Lancet Group)
Explorez tous les épisodes de The Lancet Respiratory Medicine in conversation with
| Date | Titre | Durée | |
|---|---|---|---|
| 18 Feb 2022 | Dinh Bui on preterm birth and lung function deficits | 00:05:31 | |
Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53. Continue this conversation on social! | |||
| 07 Apr 2022 | Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID | 00:14:46 | |
Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection. Continue this conversation on social! | |||
| 08 Apr 2022 | Ablo Wachinou on sleep disordered breathing in Benin | 00:10:39 | |
Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved. Continue this conversation on social! | |||
| 24 May 2022 | Daiana Stolz on antibiotic stewardship in pneumonia | 00:10:16 | |
Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection. Continue this conversation on social! | |||
| 15 Jun 2022 | Daniel Munblit and Dale Needham on core outcomes post-COVID-19 | 00:16:37 | |
Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition. Continue this conversation on social! | |||
| 26 Jul 2022 | Rachael Evans on living with long COVID | 00:13:28 | |
Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study. Continue this conversation on social! | |||
| 31 Jul 2022 | Yves Lacasse on long-term oxygen therapy for COPD | 00:17:15 | |
Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD. Continue this conversation on social! | |||
| 23 Nov 2022 | Vivienne Kahlmann and Catharina Moor on the TIRED study | 00:09:00 | |
Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis. Continue this conversation on social! | |||
| 22 Dec 2022 | Emma Grainger on 10 years of The Lancet Respiratory Medicine | 00:13:06 | |
Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal. Continue this conversation on social! | |||
| 09 Feb 2023 | Carol Hodgson on post-discharge outcomes for ECMO patients | 00:19:16 | |
Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO. Continue this conversation on social! | |||
| 06 Mar 2023 | Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer | 00:05:51 | |
Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less. Continue this conversation on social! | |||
| 21 Mar 2023 | Richard Costello on management of uncontrolled asthma | 00:11:38 | |
Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma. Continue this conversation on social! | |||
| 26 Apr 2023 | James Chalmers on bronchiectasis across Europe | 00:11:57 | |
Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry. Continue this conversation on social! | |||
| 13 Sep 2023 | Keith Chappell on a bivalent recombinant vaccine for COVID-19 | 00:08:13 | |
Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials. Continue this conversation on social! | |||
| 04 Oct 2023 | Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 | 00:12:02 | |
Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19. Continue this conversation on social! | |||
| 02 Nov 2023 | Sarah Gorst and Tim Nicholson on long COVID outcomes | 00:15:32 | |
Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care. Continue this conversation on social! | |||
| 16 Jan 2024 | Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID | 00:08:16 | |
Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2. Continue this conversation on social! | |||
| 12 Mar 2024 | Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC | 00:10:23 | |
Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer. Continue this conversation on social! | |||
| 24 Apr 2024 | Anne Chang on the burden of chronic respiratory diseases in Indigenous people | 00:09:49 | |
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people. Continue this conversation on social! | |||
| 10 May 2024 | Eric Lim on treatments for pleural mesothelioma | 00:06:17 | |
Professor Eric Lim discusses the outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone for pleural mesothelioma. Continue this conversation on social! | |||
| 25 Jul 2024 | James Hull on protecting the respiratory health of athletes | 00:11:04 | |
Professor James Hull joins us to discuss his recent Spotlight on protecting the respiratory health of athletes ahead of the Summer Olympics and Paralympics. Continue this conversation on social! | |||
| 07 Aug 2024 | Margaux Mesle on lives saved by COVID-19 vaccination | 00:10:21 | |
Dr Margaux Mesle discusses estimates of lives directly saved by COVID-19 vaccination programs in the WHO European Region in the period from 2020 to 2023 and public health implications. Continue this conversation on social! | |||
| 09 Sep 2024 | Heather Zar on early-life RSV disease and long-term respiratory health | 00:19:07 | |
Professor Heather Zar joins The Lancet Respiratory Medicine to discuss early-life RSV disease and long-term respiratory health. This topic will be covered in one of four Series papers in a cross-journal Series with The Lancet. Continue this conversation on social! | |||
| 11 Oct 2024 | Robert Kullberg on empirical antibiotics for Sepsis | 00:12:06 | |
Dr Robert Kullberg joins us to discuss his Viewpoint on empiric antibiotic therapy for sepsis and the importance of reducing unnecessary use of anti-anaerobic antibiotics. Continue this conversation on social! | |||
| 25 Oct 2024 | Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM) | 00:10:26 | |
Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM). Continue this conversation on social! | |||
| 25 Oct 2024 | Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian) | 00:10:40 | |
Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM). Continue this conversation on social! | |||
| 19 Feb 2025 | Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension | 00:14:53 | |
Dr Sandeep Sahay and Professor Franck Rahaghi discuss their Personal View on future treatment paradigms in pulmonary arterial hypertension. Read the full paper, Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients, here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00425-9/fulltext Continue this conversation on social! | |||
| 07 Apr 2025 | Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019 | 00:11:47 | |
Deputy Editor of The Lancet Respiratory Medicine Ari Colosio discusses the critical findings of a new epidemiological study on pulmonary embolism in children and adolescents with Simon Wolf from the University Hospital of Zurich. This episode delves into the prevalence, risk factors, and clinical implications of this rare but serious condition, highlighting the need for increased awareness and further research. Read the full article: Continue this conversation on social! | |||
| 11 Nov 2020 | The second wave and homeless populations | 00:07:57 | |
Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19. Continue this conversation on social! | |||
| 18 Dec 2020 | COVID-19 and severe influenza | 00:08:08 | |
Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. Continue this conversation on social! | |||
| 05 Jan 2021 | Treatment options in patients with systemic sclerosis-associated interstitial lung disease | 00:15:45 | |
Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate. Continue this conversation on social! | |||
| 12 Jan 2021 | Evaluating deterioration in patients with acute COVID-19 | 00:08:29 | |
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19. Continue this conversation on social! | |||
| 06 Feb 2021 | Interferon treatment and COVID-19 | 00:06:34 | |
Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients. Continue this conversation on social! | |||
| 05 Mar 2021 | Tocilizumab and COVID-19 | 00:05:45 | |
Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. Continue this conversation on social! | |||
| 15 Apr 2021 | Inhaled budesonide in the treatment of early COVID-19 | 00:10:24 | |
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Continue this conversation on social! | |||
| 16 Apr 2021 | Mepolizumab and the treatment of chronic rhinosinusitis | 00:07:18 | |
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Continue this conversation on social! | |||
| 11 May 2021 | Fan Chung on chronic cough and long COVID | 00:11:32 | |
Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome. Continue this conversation on social! | |||
| 14 May 2021 | Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia | 00:09:54 | |
Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia. Continue this conversation on social! | |||
| 17 May 2021 | Ignacio Rubio on COVID-19 pathophysiology and phenotypes | 00:09:19 | |
Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease. Continue this conversation on social! | |||
| 26 May 2021 | Paul Verweij on COVID-19 associated aspergillosis | 00:06:36 | |
Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis. Continue this conversation on social! | |||
| 10 Jul 2021 | Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma | 00:13:17 | |
Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma. Continue this conversation on social! | |||
| 03 Aug 2021 | Charles Sprung and authors on end-of-life practices in ICUs globally | 00:15:41 | |
Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries. Continue this conversation on social! | |||
| 20 Aug 2021 | Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 | 00:12:04 | |
Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.
Continue this conversation on social! | |||
| 06 Sep 2021 | Michael Kreuter on interstitial lung disease | 00:08:28 | |
Comment author Michael Kreuter discusses a series of papers published in The Lancet and The Lancet Respiratory Medicine on interstitial lung disease. Continue this conversation on social! | |||
| 30 Nov 2021 | Daniel Altmann on COVID boosters | 00:16:11 | |
Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes. Continue this conversation on social! | |||
| 30 Dec 2021 | Eileen Rubin on patient-centered ARDS | 00:17:05 | |
Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients. Continue this conversation on social! | |||
| 11 Jan 2022 | Wisia Wedzicha on a vaccine for COPD | 00:09:05 | |
Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research. Continue this conversation on social! | |||
| 31 Jan 2022 | Ruvim Izĭckson on a joint flu and COVID-19 vaccine | 00:08:41 | |
Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older. Continue this conversation on social! | |||
| 17 Dec 2016 | Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: January 2017 | 00:16:24 | |
Simon Hart provides an overview of the January issue of The Lancet Respiratory Medicine, which focuses on idiopathic pulmonary fibrosis. Continue this conversation on social! | |||
| 18 Nov 2016 | Lung transplantation & preservation: The Lancet Respiratory Medicine: 17 November 2016 | 00:07:28 | |
Marcelo Cypel discusses his findings on the use of ex-vivo lung perfusion in preserving transplantable lungs. Continue this conversation on social! | |||
| 21 Nov 2016 | Bronchiectasis: The Lancet Respiratory Medicine: 21 November 2016 | 00:12:50 | |
Melissa McDonnell discusses a new index used to predict mortality and disease outcomes for patients with bronchiectasis. Continue this conversation on social! | |||
| 25 Oct 2016 | Sleep apnoea & heart failure: The Lancet Respiratory Medicine: November issue | 00:06:16 | |
Christine Eulenburg discusses her study of the SERVE-HF trial. Continue this conversation on social! | |||
| 01 Oct 2016 | Smoking and mental health: The Lancet Respiratory Medicine: 30 September 2016 | 00:06:13 | |
Professor Wayne Hall talks about the challenge of reducing smoking in people with serious mental illness. Continue this conversation on social! | |||
| 01 Jun 2017 | ARDS 50th anniversary issue: The Lancet Respiratory Medicine: June 2017 issue | 00:08:31 | |
2017 marks the 50th anniversary of the first description of acute respiratory distress syndrome in a study published in The Lancet. To mark this, The Lancet Respiratory Medicine’s June issue is themed around ARDS and critical care. Here, TLRM's Laura Feetham talks to Michael Matthay about recent advances in the field of ARDS. Continue this conversation on social! | |||
| 04 Oct 2017 | Vitamin D supplementation and asthma exacerbations: The Lancet Respiratory Medicine: October 3, 2017 | 00:10:16 | |
Adrian Martineau discusses his meta-analysis of individual patient data assessing whether vitamin D supplementation can help prevent asthma exacerbations. Continue this conversation on social! | |||
| 07 Apr 2017 | Point of care molecular testing: The Lancet Respiratory Medicine: April 5, 2017 | 00:07:20 | |
Andy Pavia discusses point of care testing for respiratory virus infection. Continue this conversation on social! | |||
| 05 Jul 2017 | Defining neonatal ARDS: The Lancet Respiratory Medicine: July 4, 2017 | 00:05:40 | |
Daniele de Luca discusses his Position Paper, the first to provide a consensus definition of acute respiratory distress syndrome in neonates. Continue this conversation on social! | |||
| 10 Jan 2017 | COPD Exacerbation Treatments Around the World: The Lancet Respiratory Medicine: January 2017 | 00:09:08 | |
A look at the way COPD exacerbations are treated around the world. Continue this conversation on social! | |||
| 14 Oct 2017 | Palliative care in ILD: The Lancet Respiratory Medicine: October 12, 2017 | 00:07:25 | |
Michael Kreuter highlights the importance of palliative care for patients with interstitial lung disease. Continue this conversation on social! | |||
| 14 Dec 2017 | Breathing exercises for asthma: The Lancet Respiratory Medicine: December 13, 2017 | 00:13:45 | |
Mike Thomas talks about his trial of self-taught breathing retraining as a treatment for asthma. Continue this conversation on social! | |||
| 15 Nov 2017 | Lung function in early life and future health: The Lancet Respiratory Medicine: November 14, 2017 | 00:09:09 | |
Alvar Agusti discusses his study investigating low lung function in early adulthood and the effects this has on future health. Continue this conversation on social! | |||
| 14 Jun 2017 | Geo-economic variations in ARDS: The Lancet Respiratory Medicine: June 14, 2017 | 00:06:43 | |
John Laffey discusses his geo-economic analysis of the LUNG SAFE study, and its implications for global clinical practice. Continue this conversation on social! | |||
| 21 Apr 2017 | Talking about the March for Science: The Lancet Respiratory Medicine: April 20, 2017 | 00:12:18 | |
Aaron van Dorn speaks with March for Science co-chair Jonathan Berman and march participant Elliott Haut, a trauma and critical care surgeon, about politics and science. Continue this conversation on social! | |||
| 22 Jul 2017 | Statins for delirium: The Lancet Respiratory Medicine: July 21, 2017 | 00:06:47 | |
Valerie Page discusses the use of a statin, simvastatin, to help patients with delirium in the intensive care unit. Continue this conversation on social! | |||
| 21 Mar 2017 | De-adoption of practices in critical care: The Lancet Respiratory Medicine: March, 2017 | 00:08:26 | |
Robert Hyzy talks to Laura Feetham about how to encourage critical care doctors to stop employing ineffective practices. Continue this conversation on social! | |||
| 23 Jun 2017 | Antacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017 | 00:11:55 | |
Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy. Continue this conversation on social! | |||
| 24 Mar 2017 | World TB Day 2017: The Lancet Respiratory Medicine: March 24, 2017 | 00:07:36 | |
To mark World TB Day and the launch of a major new commission on drug-resistant tuberculosis, The Lancet Respiratory Medicine's April issue is about TB. In this podcast, Aaron van Dorn interviews Stephen Gillespie about the special issue Continue this conversation on social! | |||
| 26 Aug 2017 | Eosinophils in COPD: The Lancet Respiratory Medicine: September 2017 | 00:05:18 | |
Mona Bafadhel discusses her work on using eosinophils as biomarkers in chronic obstructive pulmonary disease. Continue this conversation on social! | |||
| 30 Sep 2017 | ICS in toddler wheeze: The Lancet Respiratory Medicine: October 2017 | 00:05:25 | |
Elissa Abrams discusses inhaled corticosteroids and wheeze in toddlers. Continue this conversation on social! | |||
| 20 Apr 2018 | Primary graft dysfunction in lung transplantation | 00:22:32 | |
Allan Glanville joins The Lancet Respiratory Medicine to discuss the INSPIRE trial that assesses the use of the Portable Organ Care System to reduce primary graft dysfunction in bilateral lung transplantation. Continue this conversation on social! | |||
| 03 Aug 2018 | Precision medicine in ARDS | 00:07:00 | |
Carolyn Calfee joins The Lancet Respiratory Medicine to discuss precision medicine approaches to acute respiratory distress syndrome, or ARDS. Continue this conversation on social! | |||
| 02 Nov 2018 | Laparoscopic anti-reflux surgery and IPF | 00:09:08 | |
Dr. Ganesh Raghu discusses the highly anticipated results of the WRAP-IPF trial, borne out of debate surrounding the role of GER in the pathogenesis and progression of IPF, and conflicting findings from retrospective studies of antacid therapies on survival and disease progression. Continue this conversation on social! | |||
| 02 Aug 2018 | Invasive aspergillosis in patients with influenza | 00:10:59 | |
Bart Rijnders joins The Lancet Respiratory Medicine to discuss his new paper on patients with severe influenza developing invasive pulmonary aspergillosis. Continue this conversation on social! | |||
| 11 Jul 2018 | Drug-resistant tuberculosis in South Africa and bedaquiline | 00:14:23 | |
Jennifer Furin joins The Lancet Respiratory Medicine to discuss the use of bedaquiline to combat multi-drug resistant tuberculosis in South Africa. Continue this conversation on social! | |||
| 05 Jul 2018 | The role of small airways in chronic obstructive pulmonary disease | 00:06:59 | |
Tillie Hackett joins The Lancet Respiratory Medicine to discuss her study assessing small airways in chronic obstructive pulmonary disease. Continue this conversation on social! | |||
| 24 Mar 2018 | World TB Day | 00:15:43 | |
Keertan Dheda joins The Lancet Respiratory Medicine to discuss the hottest topics in TB control and treatment. Continue this conversation on social! | |||
| 17 May 2018 | Cystic fibrosis | 00:10:31 | |
Julian Forton joins The Lancet Respiratory Medicine to talk about his new study into lower airway bacterial sampling in young children with cystic fibrosis. Continue this conversation on social! | |||
| 16 Nov 2018 | Effectiveness of flu vaccine over time | 00:15:16 | |
Ben Cowling discusses his work in Hong Kong investigating the effectiveness of the flu vaccine over time. Continue this conversation on social! | |||
| 12 Nov 2018 | Towards an International Pneumonia Network | 00:07:04 | |
To mark World Pneumonia Day, The Lancet Respiratory Medicine talks with Stefano Aliberti about his Comment calling for international action to tackle pneumonia. Continue this conversation on social! | |||
| 17 Sep 2018 | Deep learning and fibrotic lung disease | 00:10:09 | |
Simon Walsh discusses the potential for machine learning-assisted diagnosis of fibrotic lung disease. Continue this conversation on social! | |||
| 27 Feb 2018 | Critical care | 00:10:45 | |
Valerie Page joins The Lancet Respiratory Medicine to discuss the new themed issue on the subject of critical care. Continue this conversation on social! | |||
| 04 May 2018 | Use of a rare disease patient registry in long-term post-authorisation drug studies | 00:09:22 | |
Dr. Diana Bilton joins The Lancet Respiratory Medicine to discuss how the use of rare disease patient registries helps with long term drug studies after drug authorisation. Continue this conversation on social! | |||
| 20 Sep 2018 | Improving the lives of patients with bronchiectasis | 00:10:36 | |
Anne Chang discusses bronchiectasis, a debilitating condition of the airways. Continue this conversation on social! | |||
| 15 Sep 2018 | Critical care and infant nutrition | 00:11:34 | |
Greet Van den Berghe discusses issues of infant nutrition and critical care. Continue this conversation on social! | |||
| 22 Feb 2019 | A global approach to children's asthma | 00:06:28 | |
Dr. Warren Lenney calls for global children’s charter focusing on the diagnosis and treatment of childhood asthma globally Continue this conversation on social! | |||
| 14 Feb 2019 | The effectiveness of pleural manometry | 00:10:07 | |
Fabien Maldonado discusses the effectiveness of pleural manometry to monitor pleural pressure during thoracentesis procedures. Continue this conversation on social! | |||
| 08 Feb 2019 | Lung volume reduction and emphysema | 00:06:22 | |
Professor Pallav Shah discuses surgical and endoscopic interventions that reduce lung volume for emphysema. Continue this conversation on social! | |||
| 16 Aug 2019 | Antibiotics and non-severe exacerbations of bronchiectasis in children | 00:05:39 | |
Dr Vikas Goyal discuses the use of oral antibiotic treatment in non-severe exacerbations of bronchiectasis in children. Continue this conversation on social! | |||
| 29 Sep 2019 | Looking to the future of cystic fibrosis care | 00:08:38 | |
Dr Scott Bell and Dr Felix Ratjen discuss The Lancet Respiratory Medicine's Cystic Fibrosis Commission on the future of cystic fibrosis care. Continue this conversation on social! | |||
| 17 Apr 2019 | A respiratory family affair | 00:10:19 | |
François Maltais and Yohan Bossè discuss their investigation of five generations of a French-Canadian family with multiple recurring cases of early emphysema. Continue this conversation on social! | |||
| 28 Nov 2019 | CPAP and mild obstructive sleep apnea | 00:06:25 | |
Authors of the MERGE Trial discuss treatment of mild obstructive sleep apnea and the effectiveness of continuous positive airway pressure, or CPAP, in the treatment of patients with mild OSA Continue this conversation on social! | |||
| 08 Jan 2019 | Glimmers of hope for MDR-Tuberculosis treatment | 00:08:38 | |
Dr Raj Gupta discusses the potential of delaminid, one of the first new TB drugs to enter the market in 40 years, to offer new hope for treatment of multi drug resistant tuberculosis. Continue this conversation on social! | |||
| 05 Oct 2019 | Lung transplants from Hepatitis C viremic donors | 00:06:20 | |
Dr. Marcelo Cypel discusses a trial looking at lung transplantation from Hepatitis C viremic donors. Continue this conversation on social! | |||
| 30 Jul 2019 | α1-antitrypsin deficiency testing | 00:08:09 | |
Alex Franciosi talks with The Lancet Respiratory Medicine about the pitfalls and caveats of testing for α1-antitrypsin deficiency. Continue this conversation on social! | |||
| 06 Aug 2019 | Use of extended-criteria donors for lung transplantation | 00:08:39 | |
Dr Gabriel Loor discusses a new study looking at how the normothermic portable Organ Care System works to improve donor lungs for transplantation. Continue this conversation on social! | |||
| 19 Jun 2019 | Clearing the air on ambient air pollution | 00:04:59 | |
Dr Annette Peters addresses the current debate about the science behind European air quality standards, and why ambient air pollution deserves serious attention. Continue this conversation on social! | |||
| 24 Jun 2019 | Live-attenuated influenza vaccines in children | 00:12:05 | |
Thushan de Silva, from the Medical Research Council Unit in The Gambia, discusses a new study looking at the immunogenicity of live-attenuated influenza vaccines among children in The Gambia. Continue this conversation on social! | |||
| 21 May 2019 | Intensive care units and the USA | 00:12:24 | |
Use of intensive care unit (ICU) resources in the USA outpaces the rest of the world. The Lancet Respiratory Medicine spoke with Dr James Downar about why ICU usage in the USA is so high, what that means for care, and what can be done about it. Continue this conversation on social! | |||
| 12 Jun 2019 | A second look at FEAST | 00:10:12 | |
Dr John Myburgh discusses a reanalysis by Levin and colleagues of the FEAST trial, which looked at the adverse effects of the administration of saline or albumin fluid bolus in resuscitation. Continue this conversation on social! | |||
| 27 Sep 2019 | Pamrevlumab and idiopathic pulmonary fibrosis | 00:06:27 | |
Dr. Luca Richeldi discusses a trial looking at pamrevlumab, an anti-connective tissue growth factor therapy for the treatment of idiopathic pulmonary fibrosi Continue this conversation on social! | |||